Results 211 to 220 of about 128,641 (342)

Inhibition of methylprednisolone elimination in the presence of erythromycin therapy

open access: bronze, 1983
C LAFORCE   +4 more
openalex   +1 more source

Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid‐refractory acute graft‐versus‐host disease treatment

open access: yesBritish Journal of Haematology, EarlyView.
Summary Steroid‐refractory acute graft‐versus‐host disease (SR‐aGvHD) remains a significant challenge after haematopoietic cell transplantation (HCT). While ruxolitinib (RUX) has shown efficacy for SR‐aGvHD, failure predictors are poorly defined. We assessed 78 patients from six Canadian centres who received RUX for SR‐aGvHD. Failure‐free survival (FFS)
Sergio Rodriguez‐Rodriguez   +18 more
wiley   +1 more source

METHYLPREDNISOLONE DISPOSITION IN RENAL TRANSPLANT RECIPIENTS RECEIVING TRIPLE-DRUG IMMUNOSUPPRESSION

open access: bronze, 1989
Kathleen M. Tornatore   +3 more
openalex   +1 more source

Prognostic significance of pretransplant 18F‐FDG PET/CT metrics in relapsed/refractory diffuse large B‐cell lymphoma with partial response to salvage chemotherapy prior to autologous stem cell transplantation

open access: yesBritish Journal of Haematology, EarlyView.
Summary Relapsed/refractory diffuse large B‐cell lymphoma (R/R DLBCL) patients with partial response (PR) to salvage chemotherapy show heterogeneous outcomes after autologous stem cell transplantation (ASCT). Current visual positron emission tomography (PET) assessment inadequately identifies patients likely to benefit from transplantation.
Minseung Suh   +15 more
wiley   +1 more source

Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone.

open access: bronze, 1980
W. Michael Scheld   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy